Bioss

Bioss Antibodies is a globally recognized leader in antibody development and manufacturing, offering a comprehensive portfolio of over 12,000 primary antibodies and an extensive range of more than 300,000 derived products. These include highly reliable loading control antibodies, tag antibodies, and fluorochrome-conjugated antibodies, all designed to meet the rigorous demands of modern research.

In addition to antibodies, Bioss provides high-quality recombinant proteins, ready-to-use immunohistochemistry (IHC) kits, ELISA kits, and essential materials for in vitro diagnostic (IVD) kits, supporting a wide range of applications in biomedical research, diagnostics, and drug development.

With a presence in more than 50 countries, Bioss has been a trusted partner for scientists worldwide for over a decade. The company is dedicated to advancing biological research by delivering innovative, reproducible, and high-performance solutions, along with a commitment to strong customer support.

Their Mission:

Bioss Antibodies is dedicated to advancing biological research by developing and manufacturing high-quality, reliable antibodies and research tools. With a focus on innovation, precision, and reproducibility, Bioss empowers scientists worldwide to accelerate discoveries in biomedical science, diagnostics, and therapeutics. By continuously improving and expanding its product offerings, Bioss remains a trusted partner in driving scientific progress and medical breakthroughs.